Literature DB >> 1458329

Equine uveitis.

K L Schwink1.   

Abstract

Uveitis (inflammation of the iris, ciliary body, or choroid) is a potentially blinding condition with a significant economic impact on the horse industry. Variable symptoms are described, as well as a considerable range of structural and functional sequelae. Known causes of initial episodes include bacterial, viral, traumatic, and parasitic insults, with recurrence by immunologic mechanisms. Treatment strategies and management recommendations that may reduce the incidence or severity of episodes are discussed.

Entities:  

Mesh：

Year:  1992        PMID： 1458329     DOI： 10.1016/s0749-0739(17)30441-8

Source DB:  PubMed          Journal:  Vet Clin North Am Equine Pract        ISSN： 0749-0739            Impact factor:   1.792


  9 in total

1.  Diagnostic ophthalmology. Anterior and posterior uveitis with inflammatory retinal detachment, most likely secondary to equine recurrent uveitis.

Authors:  Lynne S Sandmeyer; Bruce H Grahn; Carrie B Breaux
Journal:  Can Vet J       Date:  2007-01       Impact factor: 1.008

2.  Detection of Leptospira spp. in the aqueous humor of horses with naturally acquired recurrent uveitis.

Authors:  N A Faber; M Crawford; R B LeFebvre; N C Buyukmihci; J E Madigan; N H Willits
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

Review 3.  Infectious Uveitis in Horses and New Insights in Its Leptospiral Biofilm-Related Pathogenesis.

Authors:  Bettina Wollanke; Hartmut Gerhards; Kerstin Ackermann
Journal:  Microorganisms       Date:  2022-02-07

4.  Open label safety and efficacy pilot to study mitigation of equine recurrent uveitis through topical suppressor of cytokine signaling-1 mimetic peptide.

Authors:  Caryn E Plummer; Timothy Polk; Jatin Sharma; Sanghyo Sarah Bae; Olivia Barr; Amari Jones; Holly Kitchen; Michelle Wilhelmy; K Devin; W Clay Smith; Bryan D Kolaczkowski; Joseph Larkin
Journal:  Sci Rep       Date:  2022-05-03       Impact factor: 4.996

5.  Cross-reactivity of antibodies against leptospiral recurrent uveitis-associated proteins A and B (LruA and LruB) with eye proteins.

Authors:  Ashutosh Verma; Pawan Kumar; Kelly Babb; John F Timoney; Brian Stevenson
Journal:  PLoS Negl Trop Dis       Date:  2010-08-03

6.  Unraveling the equine lymphocyte proteome: differential septin 7 expression associates with immune cells in equine recurrent uveitis.

Authors:  Roxane L Degroote; Stefanie M Hauck; Barbara Amann; Sieglinde Hirmer; Marius Ueffing; Cornelia A Deeg
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

7.  Horses with equine recurrent uveitis have an activated CD4+ T-cell phenotype that can be modulated by mesenchymal stem cells in vitro.

Authors:  Laurel K Saldinger; Seldy G Nelson; Rebecca R Bellone; Mary Lassaline; Maura Mack; Naomi J Walker; Dori L Borjesson
Journal:  Vet Ophthalmol       Date:  2019-08-22       Impact factor: 1.644

8.  Analysis of 1840 Equine Intraocular Fluid Samples for the Presence of Anti-Leptospira Antibodies and Leptospiral DNA and the Correlation to Ophthalmologic Findings in Terms of Equine Recurrent Uveitis (ERU)-A Retrospective Study.

Authors:  Tobias Geiger; Hartmut Gerhards; Bogdan Bjelica; Elke Mackenthun; Bettina Wollanke
Journal:  Vet Sci       Date:  2022-08-21

9.  Neutrophil Extracellular Traps in the Pathogenesis of Equine Recurrent Uveitis (ERU).

Authors:  Leonie Fingerhut; Bernhard Ohnesorge; Myriam von Borstel; Ariane Schumski; Katrin Strutzberg-Minder; Matthias Mörgelin; Cornelia A Deeg; Henk P Haagsman; Andreas Beineke; Maren von Köckritz-Blickwede; Nicole de Buhr
Journal:  Cells       Date:  2019-11-27       Impact factor: 6.600
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.